Filtered By:
Source: PM and R
Education: Study
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 53 results found since Jan 2013.
Tone-inhibiting insoles enhance the reciprocal inhibition of ankle plantarflexors of post-stroke hemiparetic subjects: an electromyographic study
Spasticity is a common sequela of upper motor neuron pathology, such as cerebrovascular diseases and cerebral palsy. Intervention for spasticity of the ankle plantarflexors in physical therapy may include tone-inhibiting casting and/or orthoses for the ankle and foot. However, the physiological mechanism of tone reduction by such orthoses remains unclarified.
Source: PM and R - July 20, 2017 Category: Rehabilitation Authors: Nobushige Takahashi, Hidetoshi Takahashi, Osamu Takahashi, Ryosuke Ushijima, Rie Umebayashi, Junji Nishikawa, Yasutomo Okajima Source Type: research
Tone-Inhibiting Insoles Enhance the Reciprocal Inhibition of Ankle Plantarflexors of Subjects With Hemiparesis After Stroke: An Electromyographic Study
Spasticity is a common sequela of upper motor neuron pathology, such as cerebrovascular diseases and cerebral palsy. Intervention for spasticity of the ankle plantarflexors in physical therapy may include tone-inhibiting casting and/or orthoses for the ankle and foot. However, the physiological mechanism of tone reduction by such orthoses remains unclarified.
Source: PM and R - July 20, 2017 Category: Rehabilitation Authors: Nobushige Takahashi, Hidetoshi Takahashi, Osamu Takahashi, Ryosuke Ushijima, Rie Umebayashi, Junji Nishikawa, Yasutomo Okajima Tags: Original Research Source Type: research
Poster 471: SIAXI: Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Sialorrhea in Parkinson ’s Disease (PD), Stroke, and Other Neurological Conditions: Results of a Phase III, Placebo-Controlled, Randomized, Double-Blind Study
Andrew Blitzer: Research Grants - Merz
Source: PM and R - September 1, 2017 Category: Rehabilitation Authors: Andrew Blitzer, Andrzej Friedman, Olaf Michel, Birgit Flatau-Baqu é, János Csikós, Wolfgang Jost Tags: Category: Neurological Rehabilitation Source Type: research
Poster 470: Safety and Tolerability of Transcranial Direct Current Stimulation to Stroke Patients – A Phase I Current Escalation Study
Wuwei Feng: I Have No Relevant Financial Relationships To Disclose
Source: PM and R - September 1, 2017 Category: Rehabilitation Authors: Wuwei Feng, Pratik Y. Chhatbar, Steven A. Kautz, Mark George Tags: Category: Neurological Rehabilitation Source Type: research
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study
Dextromethorphan 20mg /quinidine 10mg (DM/Q) was approved to treat pseudobulbar affect (PBA) based upon phase 3 trials conducted in participants with amyotrophic lateral sclerosis or multiple sclerosis. PRISM II evaluated DM/Q effectiveness, safety and tolerability for PBA following stroke, dementia or traumatic brain injury (TBI). Objective. To report results from the TBI cohort of PRISM II, including a TBI-specific functional scale. Design. Open-label trial evaluating twice daily DM/Q over 90 days.
Source: PM and R - February 22, 2018 Category: Rehabilitation Authors: Flora M. Hammond, William Sauve, Fred Ledon, Charles Davis, Andrea E. Formella Source Type: research
Functional Outcomes of an Interdisciplinary Outpatient Rehabilitation Program for Patients with Malignant Brain Tumors
Malignant brain tumors cause significant impairments in function due to nature of the disease. Patients with malignant brain tumors can make functional gains equivalent to those with stroke and traumatic brain injury in the inpatient rehabilitation setting. However, the efficacy of outpatient rehabilitation in this population has received little study.
Source: PM and R - March 14, 2018 Category: Rehabilitation Authors: Samman Shahpar, Alex W.K. Wong, Susan Keeshin, Sarah Eickmeyer, Patrick Semik, Masha Kocherginsky, Stacy McCarty Source Type: research
Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study
Dextromethorphan 20 mg / quinidine 10 mg (DM/Q) was approved to treat pseudobulbar affect (PBA) based on phase 3 trials conducted in participants with amyotrophic lateral sclerosis or multiple sclerosis. PRISM II evaluated DM/Q effectiveness, safety, and tolerability for PBA following stroke, dementia, or traumatic brain injury (TBI).
Source: PM and R - February 22, 2018 Category: Rehabilitation Authors: Flora M. Hammond, William Sauve, Fred Ledon, Charles Davis, Andrea E. Formella Tags: Original Research Source Type: research
